delafloxacin meglumine (baxdela) Report issue

Small molecule Approved FDA Fast Track FDA Priority Review FDA
Drugs@FDA
Back

Drug Pricing Summary

VA Big4

$28.7505 - $605.0100

VA FSS

$28.7505 - $605.0100

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
delafloxacin meglumine 300 mg / 10.5 mL (10.5 mL INJECTION) $605.0100 VA Big4
  • Baxdela (1)
    		•  Melinta Therapeutics, Inc.
    delafloxacin meglumine 300 mg / 10.5 mL (10.5 mL INJECTION) $605.0100 VA FSS
  • Baxdela (1)
    		•  Melinta Therapeutics, Inc.
    delafloxacin meglumine 450 mg (TABLET) $28.7505 VA Big4
  • Baxdela (20)
    		•  Melinta Therapeutics, Inc.
  • Baxdela (20)
    		•  Melinta Therapeutics, Inc.
    delafloxacin meglumine 450 mg (TABLET) $28.7505 VA FSS
  • Baxdela (20)
    		•  Melinta Therapeutics, Inc.
  • Baxdela (20)
    		•  Melinta Therapeutics, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue